Rigel Pharmaceuticals, Inc. (RIGL)
35.46
-1.18
(-3.22%)
USD |
NASDAQ |
Feb 20, 16:00
35.45
-0.01
(-0.03%)
After-Hours: 20:00
Rigel Pharmaceuticals Total Assets (Quarterly) : 242.53M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Nektar Therapeutics | 301.35M |
| Eli Lilly & Co. | 112.48B |
| Ironwood Pharmaceuticals, Inc. | 396.06M |
| BioMarin Pharmaceutical, Inc. | 7.615B |
| Catalyst Pharmaceuticals, Inc. | 1.052B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 124.92M |
| Shareholders Equity (Quarterly) | 117.61M |
| Debt to Equity Ratio | 0.5176 |
| Current Ratio | 2.277 |
| Net Debt Paydown Yield | -0.02% |